Small company gets U.S. go-ahead on bird flu patch


  • World Premium
  • Wednesday, 16 Apr 2008

WASHINGTON (Reuters) - A small biotechnology company trying to develop needle-free vaccines won a boost to its efforts on Tuesday with U.S. government approval to test a bird flu skin patch on more people.

Iomai's patch is not a vaccine, but rather delivers what is called an adjuvant -- an immune boosting agent that will be delivered along with a vaccine to try to make it work better.

Article type: metered
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights
   

Next In World

A year after Myanmar's coup, families of detainees search for answers Premium
U.S. plans to reroute $67 million in aid towards Lebanon's armed forces Premium
Lebanon will not 'hand over' Hezbollah arms at Gulf meeting, minister says Premium
Ukrainian troops train with new British arms amid Russia tensions Premium
'Horrific' destruction, casualties if Russia invades Ukraine -U.S. Premium
Working with U.S., Guatemala detains 10 people in raids on migrant smugglers Premium
Ukraine's president lashes out at too much 'panic' over Russia tensions Premium
Beleaguered Trudeau rival embraces trucker protest despite concerns of violence Premium
Biden administration to deny $130 million in military aid to Egypt -sources Premium
Exclusive-Russia moves blood supplies near Ukraine, adding to U.S. concern, officials say Premium

Others Also Read


Vouchers